Literature DB >> 23888364

Ocular vasculitis.

Gabriela M Espinoza1, Ankit Desai, Levent Akduman.   

Abstract

Vasculitis is the inflammation of blood vessels that leads to loss of perfusion and ischemia with necrosis. When this occurs in the orbit, the consequences are typically very conspicuous and can be devastating with decreased quality of life and loss of vision. Systemic vasculitides are often related to ophthalmic disorders, which can serve as the first diagnostic manifestation of potentially life-threatening disease. Antineutrophil cytoplasmic antibody (ANCA)-associated vasculitides (e.g., granulomatosis with polyangiitis), Behcet's disease, rheumatoid arthritis, sarcoidosis, and systemic lupus erythematosus are a few of the diseases commonly associated with ocular vasculitis. Collaboration between ophthalmologists and rheumatologists is important in the successful diagnosis and treatment of patients with vasculitis.

Entities:  

Mesh:

Substances:

Year:  2013        PMID: 23888364     DOI: 10.1007/s11926-013-0355-x

Source DB:  PubMed          Journal:  Curr Rheumatol Rep        ISSN: 1523-3774            Impact factor:   4.592


  52 in total

Review 1.  Guidelines for the use of immunosuppressive drugs in patients with ocular inflammatory disorders: recommendations of an expert panel.

Authors:  D A Jabs; J T Rosenbaum; C S Foster; G N Holland; G J Jaffe; J S Louie; R B Nussenblatt; E R Stiehm; H Tessler; R N Van Gelder; S M Whitcup; D Yocum
Journal:  Am J Ophthalmol       Date:  2000-10       Impact factor: 5.258

2.  Is ICGA still relevant in inflammatory eye disorders? Why this question has to be dealt with separately from other eye conditions.

Authors:  Carl P Herbort; Piergiorgio Neri; Ahmed A El Asrar; Vishali Gupta; Philippe Kestelyn; Moncef Khairallah; Alessandro Mantovani; Ilknur Tugal-Tutkun; Marina Papadia
Journal:  Retina       Date:  2012-10       Impact factor: 4.256

3.  Clinical features and outcome of Cogan syndrome.

Authors:  Ilaria Pagnini; Maria Elisabetta Zannin; Fabio Vittadello; Marianna Sari; Gabriele Simonini; Rolando Cimaz; Francesco Zulian
Journal:  J Pediatr       Date:  2011-09-13       Impact factor: 4.406

Review 4.  Ocular manifestations of systemic disease: antineutrophil cytoplasmic antibody-associated vasculitis.

Authors:  Jean Schmidt; Jose S Pulido; Eric L Matteson
Journal:  Curr Opin Ophthalmol       Date:  2011-11       Impact factor: 3.761

5.  Behçet disease: evolution of clinical manifestations.

Authors:  Haruko Ideguchi; Akiko Suda; Mitsuhiro Takeno; Atsuhisa Ueda; Shigeru Ohno; Yoshiaki Ishigatsubo
Journal:  Medicine (Baltimore)       Date:  2011-03       Impact factor: 1.889

6.  Interferon-alpha 2a treatment of neuro-Behcet disease.

Authors:  J C Nichols; A Ince; L Akduman; E S Mann
Journal:  J Neuroophthalmol       Date:  2001-06       Impact factor: 3.042

7.  Conjunctival biopsy in sarcoidosis.

Authors:  Yu-Mei Chung; Ying-Cheng Lin; De-Feng Huang; De-Kuang Hwang; Donald M Ho
Journal:  J Chin Med Assoc       Date:  2006-10       Impact factor: 2.743

8.  Anticytoplasmic autoantibodies: their immunodiagnostic value in Wegener granulomatosis.

Authors:  B Nölle; U Specks; J Lüdemann; M S Rohrbach; R A DeRemee; W L Gross
Journal:  Ann Intern Med       Date:  1989-07-01       Impact factor: 25.391

9.  More questions than answers: a call for a moratorium on the use of intravitreal infliximab outside of a well-designed trial.

Authors:  Jose S Pulido; Jose E Pulido; Clement J Michet; Richard G Vile
Journal:  Retina       Date:  2010-01       Impact factor: 4.256

Review 10.  TNF-α blocker therapy and solid malignancy risk in ANCA-associated vasculitis.

Authors:  Francisco Silva; Marcela Cisternas; Ulrich Specks
Journal:  Curr Rheumatol Rep       Date:  2012-12       Impact factor: 4.592

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.